Letter to the Editor: androgenetic alopecia; drug safety and therapeutic strategies

Expert Opin Drug Saf. 2018 Jun;17(6):651-652. doi: 10.1080/14740338.2018.1470744. Epub 2018 May 9.

Authors

Gary Ong¹, Michael Manyak², Zrinka Lulic¹

Affiliations

¹ b GlaxoSmithKline, Research & Development , Brentford , UK.
² a GlaxoSmithKline, Research & Development , Research Triangle Park , North Carolina , USA.

PMID: 29707969
DOI: 10.1080/14740338.2018.1470744

No abstract available

Publication types

Comment

MeSH terms

Alopecia*
Finasteride*
Humans

Substances

Finasteride